Safety and Phosphate‐Binding Capacity of Oxylanthanum Carbonate in Healthy Volunteers

Ähnliche Einträge

• Genotype–Specific Safety and Pharmacokinetics of Cannabidiol in Healthy Volunteers
  von: Jumar Etkins, et al.
  Veröffentlicht: (2025)
• Correction to “Genotype‐Specific Safety and Pharmacokinetics of Cannabidiol in Healthy Volunteers”
  Veröffentlicht: (2026)
• Pharmacokinetics and Safety of Polaprezinc Granules Oral Administration in Healthy Chinese Volunteers Under Fasting and Fed Conditions
  von: Min Xiao, et al.
  Veröffentlicht: (2025)
• Ecopipam, a Dopamine D1 Receptor Antagonist: Pharmacokinetics, Mass Balance, and Metabolism in Healthy Volunteers
  von: Virginia D. Schmith, et al.
  Veröffentlicht: (2026)
• Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INT‐787, a Novel Farnesoid X Receptor Agonist, in Healthy Volunteers: A Phase 1 Trial
  von: Thomas Capozza, et al.
  Veröffentlicht: (2025)